Novel Nonpeptide CCK-B Antagonists: Design and Development of Quinazolinone Derivatives as Potent, Selective, and Orally Active CCK-B Antagonists
Authors:
- 1 March 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 41 (7) , 1042-1049
Abstract
We have designed a novel series of CCK-B receptor antagonists by combining key pharmacophores, an arylurea moiety of 1 and a quinazolinone ring of 3, from two known series. Our earlier studies showed that compounds with methylene linkers in our “target” produced moderate binding affinity and selectivity for CCK-B receptors, whereas its higher and lower homologues resulted in loss of affinity. Introduction of −NH− as a linker dramatically enhanced binding affinity and selectivity for CCK-B receptors, thus providing several compounds with single-digit nanomolar binding affinity and excellent selectivity. Analogous to the earlier studies of the series of quinazolinone derivatives 3, we also found 3-isopropoxyphenyl as a preferred substitution on the N-3 quinazolinone. Electron-withdrawing substitutions on the urea terminal phenyl ring enhanced the CCK-B potency. Representative compounds of this series were tested in the functional assay and showed pure antagonist profiles. Compounds 51 and 61 were orally active in the elevated rat X-maze test. These compounds were also evaluated for their pharmacokinetic profile. The absolute oral bioavailability of compound 61 was 22% in rats.Keywords
This publication has 16 references indexed in Scilit:
- Second Generation “Peptoid” CCK-B Receptor Antagonists: Identification and Development ofN-(Adamantyloxycarbonyl)-α-methyl-(R)-tryptophan Derivative (CI-1015) with an Improved Pharmacokinetic ProfileJournal of Medicinal Chemistry, 1998
- Design and synthesis of novel nonpeptide CCK-B receptor antagonistsBioorganic & Medicinal Chemistry Letters, 1997
- Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteersBiological Psychiatry, 1995
- Synthesis and x-ray crystallographic analysis of quinazolinone cholecystokinin/gastrin receptor ligandsJournal of Medicinal Chemistry, 1992
- The cholecystokinin hypothesis of panic and anxiety disorders: a reviewJournal of Psychopharmacology, 1992
- Specific anti-HIV-1 acyclonucleosides which cannot be phosphorylated: synthesis of some deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymineJournal of Medicinal Chemistry, 1991
- Preparation, characterization, and anticancer activity of a series of cis-PtCl2 complexes linked to anthraquinone intercalatorsJournal of Medicinal Chemistry, 1991
- Cloning of Shiga-like toxin structural genes from a toxin converting phage of Escherichia coliScience, 1985
- Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous systemBrain Research, 1979
- Some reactions of quinazoline-2,4(1H,3H)-dionesJournal of the Chemical Society C: Organic, 1971